Tackling the Hepatitis C Disease Burden in Punjab, India

Overview

Journal J Clin Exp Hepatol

Publisher Elsevier

Specialty Gastroenterology

Date 2016 Oct 18

PMID 27746619

Citations 20

Authors

Radha K Dhiman

Sandeep Satsangi

Gagandeep S Grover

Pankaj Puri

Affiliations

Soon will be listed here.

Abstract

Hepatitis C virus (HCV) is a globally prevalent pathogen and is a major cause of healthcare burden in India. HCV poses a significant problem in the state of Punjab, India owing to the higher prevalence of risk factors like unsafe medical practices (including unsafe injections and dental procedures) and intravenous drug use. The reported prevalence of HCV in this part of the country was 5.2% in 2012, while a recent study has shown the prevalence to be 3.2% in 2016. Similar to the other geographic belts in India, genotype 3 predominates in the state of Punjab. Control of HCV infection in Punjab requires focusing on several strategies. There is a need to formulate a health educational curriculum targeting not only the high-risk population but also the general population regarding the transmission of HCV. Training of family physicians who form the first link to patients in the community is imperative in the success of healthcare programmes. Adopting the dual approach of treating the old cases (decreasing the reservoir pool of HCV) and decreasing the incidence of new ones would help curtail the disease and decrease liver related mortality. A commendable initiative has been launched by the Punjab state government to eliminate HCV from Punjab. However, besides the initiative by the government, a concerted effort by all other stakeholders in managing the HCV burden in India, namely the doctors, the drug companies and the non-government organizations is required for control of HCV.

Citing Articles

Clinicoepidemiology and Diagnosis of Hepatitis C: Evaluating HCV Core Antigen Assay as a Diagnostic Tool in a Tertiary Care Teaching Hospital of North India.

Rautela A, Raj N, Verma A, Agarwal J, Verma P, Garg J Euroasian J Hepatogastroenterol. 2025; 14(2):176-181.

PMID: 39802859 PMC: 11714113. DOI: 10.5005/jp-journals-10018-1446.

Unsafe Injection Practices by Medical Practitioners in South Asia Associated with Hepatitis and HIV Outbreaks.

Altaf A J Infect (Grand Rapids). 2024; 1(2):1-3.

PMID: 39649014 PMC: 7617092. DOI: 10.29245/2689-9981/2018/2.1113.

The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease.

Behera M, Majji P, Behera S, Pani M, Mohapatro A, Patra U J Clin Exp Hepatol. 2024; 14(4):101367.

PMID: 38558861 PMC: 10981127. DOI: 10.1016/j.jceh.2024.101367.

Assessment of factors affecting response of direct-acting antivirals in chronic hepatitis C patients.

Jain N, Garg R, Singh G, Kaur S, Chawla S, Padda P Ann Afr Med. 2024; 22(4):456-464.

PMID: 38358146 PMC: 10775945. DOI: 10.4103/aam.aam_183_22.

Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection.

Corcorran M, Scott J, Naveira M, Easterbrook P BMC Health Serv Res. 2023; 23(1):849.

PMID: 37568106 PMC: 10422775. DOI: 10.1186/s12913-023-09777-x.

References

Alter H, Seeff L . Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000; 20(1):17-35. DOI: 10.1055/s-2000-9505. View

Radhakrishnan S, Abraham P, Raghuraman S, John G, Thomas P, Jacob C . Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India. Indian J Med Res. 2000; 111:204-11. View

Ganju S, Goel A . Prevalence of HBV and HCV infection among health care workers (HCWs). J Commun Dis. 2001; 32(3):228-30. View

Phukan A, Sharma S, Das H, Mahanta J . HCV activity in an isolated community in north east India. Indian J Pathol Microbiol. 2002; 44(4):403-5. View

Raghuraman S, Shaji R, Sridharan G, Radhakrishnan S, Chandy G, Ramakrishna B . Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol. 2003; 26(1):61-9. DOI: 10.1016/s1386-6532(02)00025-2. View

Chowdhury A, Santra A, Chaudhuri S, Dhali G, Chaudhuri S, Maity S . Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology. 2003; 37(4):802-9. DOI: 10.1053/jhep.2003.50157. View

Duseja A, Arora L, MASIH B, Singh H, Gupta A, Behera D . Hepatitis B and C virus--prevalence and prevention in health care workers. Trop Gastroenterol. 2003; 23(3):125-6. View

Das B, Kundu B, Khandapkar R, Sahni S . Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol. 2003; 45(3):323-8. View

Sood A, Midha V, Awasthi G . Hepatitis C--knowledge & practices among the family physicians. Trop Gastroenterol. 2003; 23(4):198-201. View

10.

Chandra M, Khaja M, Farees N, Poduri C, Hussain M, Habeeb M . Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in south India. Trop Gastroenterol. 2004; 24(4):193-5. View

11.

Raghuraman S, Abraham P, Sridharan G, Daniel H, Ramakrishna B, Shaji R . HCV genotype 4--an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol. 2004; 31(4):253-8. DOI: 10.1016/j.jcv.2004.03.019. View

12.

Hissar S, Goyal A, Kumar M, Pandey C, Suneetha P, Sood A . Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol. 2006; 78(4):452-8. DOI: 10.1002/jmv.20561. View

13.

Scheiblauer H, El-Nageh M, Nick S, Fields H, Prince A, Diaz S . Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion. 2006; 46(5):708-18. DOI: 10.1111/j.1537-2995.2006.00789.x. View

14.

Chandra M, Thippavuzzula R, Ramachandra Rao V, Habib A, Habibullah C, Narasu L . Genotyping of Hepatitis C virus (HCV) in infected patients from South India. Infect Genet Evol. 2007; 7(6):724-30. DOI: 10.1016/j.meegid.2007.03.001. View

15.

Kumar A, Sharma K, Gupta R, Kar P, Chakravarti A . Prevalence & risk factors for hepatitis C virus among pregnant women. Indian J Med Res. 2007; 126(3):211-5. View

16.

Verma V, Chakravarti A, Kar P . Genotypic characterization of hepatitis C virus and its significance in patients with chronic liver disease from Northern India. Diagn Microbiol Infect Dis. 2008; 61(4):408-14. DOI: 10.1016/j.diagmicrobio.2008.03.011. View

17.

Ali S, Donahue R, Qureshi H, Vermund S . Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2008; 13(1):9-19. PMC: 2651958. DOI: 10.1016/j.ijid.2008.06.019. View

18.

Narahari S, Juwle A, Basak S, Saranath D . Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort. Infect Genet Evol. 2009; 9(4):643-5. DOI: 10.1016/j.meegid.2009.04.001. View

19.

Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D . Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010; 105(5):844-59. DOI: 10.1111/j.1360-0443.2009.02888.x. View

20.

Jasuja S, Gupta A, Choudhry R, Kher V, Aggarwal D, Mishra A . Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol. 2010; 19(2):62-7. PMC: 2847810. DOI: 10.4103/0971-4065.53324. View